Total Payments
$895.54
2023 Payments
$92.89
Companies
11
Transactions
59
Medicare Patients
110
Medicare Billing
$19,839
Payment Breakdown by Category
Food & Beverage$895.54 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $895.54 | 59 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Allergan, Inc. | $368.25 | 27 | $0 (2020) |
| Janssen Biotech, Inc. | $157.71 | 11 | $0 (2019) |
| Cumberland Pharmaceuticals, Inc. | $92.89 | 4 | $0 (2023) |
| ABBVIE INC. | $84.56 | 5 | $0 (2022) |
| Melinta Therapeutics, Inc. | $55.64 | 4 | $0 (2019) |
| Merck Sharp & Dohme Corporation | $29.71 | 2 | $0 (2017) |
| Tactile Systems Technology Inc | $28.46 | 2 | $0 (2019) |
| ViiV Healthcare Company | $24.95 | 1 | $0 (2022) |
| TETRAPHASE PHARMACEUTICALS, INC. | $23.40 | 1 | $0 (2019) |
| Theravance Biopharma Inc. | $18.78 | 1 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $92.89 | 4 | Cumberland Pharmaceuticals, Inc. ($92.89) |
| 2022 | $76.69 | 4 | ABBVIE INC. ($51.74) |
| 2021 | $20.16 | 1 | AbbVie Inc. ($20.16) |
| 2020 | $36.26 | 2 | Allergan, Inc. ($36.26) |
| 2019 | $297.74 | 22 | Allergan Inc. ($116.21) |
| 2018 | $255.43 | 19 | Allergan Inc. ($147.90) |
| 2017 | $116.37 | 7 | Allergan Inc. ($67.88) |
All Payment Transactions
59 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 08/01/2023 | Cumberland Pharmaceuticals, Inc. | VIBATIV (Drug) | Food and Beverage | In-kind items and services | $28.19 | General |
| Category: INFECTIONS AND INFECTIOUS DISEASES | ||||||
| 05/30/2023 | Cumberland Pharmaceuticals, Inc. | VIBATIV (Drug) | Food and Beverage | In-kind items and services | $13.85 | General |
| Category: INFECTIONS AND INFECTIOUS DISEASES | ||||||
| 04/17/2023 | Cumberland Pharmaceuticals, Inc. | VIBATIV (Drug) | Food and Beverage | In-kind items and services | $29.02 | General |
| Category: INFECTIONS AND INFECTIOUS DISEASES | ||||||
| 04/06/2023 | Cumberland Pharmaceuticals, Inc. | VIBATIV (Drug) | Food and Beverage | In-kind items and services | $21.83 | General |
| Category: INFECTIONS AND INFECTIOUS DISEASES | ||||||
| 05/18/2022 | ABBVIE INC. | DALVANCE (Drug) | Food and Beverage | In-kind items and services | $17.00 | General |
| Category: ANTI-INFECTIVE | ||||||
| 04/07/2022 | ViiV Healthcare Company | CABENUVA (Biological) | Food and Beverage | In-kind items and services | $24.95 | General |
| Category: HIV | ||||||
| 02/24/2022 | ABBVIE INC. | DALVANCE (Drug) | Food and Beverage | In-kind items and services | $15.26 | General |
| Category: ANTI-INFECTIVE | ||||||
| 02/01/2022 | ABBVIE INC. | DALVANCE (Drug) | Food and Beverage | In-kind items and services | $19.48 | General |
| Category: ANTI-INFECTIVE | ||||||
| 07/06/2021 | AbbVie Inc. | DALVANCE (Drug) | Food and Beverage | In-kind items and services | $20.16 | General |
| Category: ANTI-INFECTIVE | ||||||
| 08/18/2020 | Allergan, Inc. | DALVANCE (Drug) | Food and Beverage | In-kind items and services | $16.14 | General |
| Category: ANTI-INFECTIVE | ||||||
| 05/07/2020 | Allergan, Inc. | DALVANCE (Drug) | Food and Beverage | In-kind items and services | $20.12 | General |
| Category: ANTI-INFECTIVE | ||||||
| 12/10/2019 | Tactile Systems Technology Inc | FLEXITOUCH (Device), ACTITOUCH, ENTRE | Food and Beverage | In-kind items and services | $16.21 | General |
| Category: PNEUMATIC COMPRESSOR | ||||||
| 12/04/2019 | Janssen Biotech, Inc. | Symtuza (Drug), Juluca | Food and Beverage | In-kind items and services | $18.52 | General |
| Category: Infectious Diseases & Vaccines | ||||||
| 10/22/2019 | Janssen Biotech, Inc. | Symtuza (Drug), Juluca | Food and Beverage | In-kind items and services | $12.45 | General |
| Category: Infectious Diseases & Vaccines | ||||||
| 09/27/2019 | Allergan Inc. | AVYCAZ (Drug) | Food and Beverage | In-kind items and services | $15.30 | General |
| Category: ANTI-INFECTIVE | ||||||
| 09/13/2019 | Janssen Biotech, Inc. | Symtuza (Drug), Juluca | Food and Beverage | In-kind items and services | $12.41 | General |
| Category: Infectious Diseases & Vaccines | ||||||
| 08/27/2019 | TETRAPHASE PHARMACEUTICALS, INC. | Xerava (Drug) | Food and Beverage | In-kind items and services | $23.40 | General |
| Category: Complicated Intra-Abdominal Infections | ||||||
| 08/27/2019 | Allergan Inc. | DALVANCE (Drug) | Food and Beverage | In-kind items and services | $14.72 | General |
| Category: ANTI-INFECTIVE | ||||||
| 08/19/2019 | Janssen Biotech, Inc. | Symtuza (Drug), Juluca | Food and Beverage | In-kind items and services | $16.43 | General |
| Category: Infectious Diseases & Vaccines | ||||||
| 07/16/2019 | Allergan Inc. | AVYCAZ (Drug) | Food and Beverage | In-kind items and services | $6.80 | General |
| Category: ANTI-INFECTIVE | ||||||
| 06/19/2019 | Allergan Inc. | AVYCAZ (Drug) | Food and Beverage | In-kind items and services | $8.59 | General |
| Category: ANTI-INFECTIVE | ||||||
| 06/03/2019 | Allergan Inc. | DALVANCE (Drug) | Food and Beverage | In-kind items and services | $11.27 | General |
| Category: ANTI-INFECTIVE | ||||||
| 05/21/2019 | Janssen Biotech, Inc. | Symtuza (Drug) | Food and Beverage | In-kind items and services | $15.70 | General |
| Category: Infectious Diseases & Vaccines | ||||||
| 04/05/2019 | Allergan Inc. | DALVANCE (Drug) | Food and Beverage | In-kind items and services | $14.53 | General |
| Category: ANTI-INFECTIVE | ||||||
| 03/29/2019 | Janssen Biotech, Inc. | Symtuza (Drug) | Food and Beverage | In-kind items and services | $18.11 | General |
| Category: Infectious Diseases & Vaccines | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2022 | 3 | 87 | 186 | $29,325 | $17,424 |
| 2021 | 1 | 12 | 13 | $2,275 | $1,418 |
| 2020 | 1 | 11 | 11 | $1,375 | $996.70 |
Total Patients
110
Total Services
210
Medicare Billing
$19,839
Procedure Codes
5
All Medicare Procedures & Services
5 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 55 | 131 | $22,925 | $13,656 | 59.6% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 17 | 37 | $3,700 | $2,182 | 59.0% |
| 97597 | Removal of tissue from wound, 20.0 sq cm or less | Office | 2022 | 15 | 18 | $2,700 | $1,586 | 58.7% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 12 | 13 | $2,275 | $1,418 | 62.3% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 11 | 11 | $1,375 | $996.70 | 72.5% |
About Dr. Vincent Pons, M.D
Dr. Vincent Pons, M.D is a Infectious Disease healthcare provider based in Novato, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/09/2010. The National Provider Identifier (NPI) number assigned to this provider is 1609181213.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Vincent Pons, M.D has received a total of $895.54 in payments from pharmaceutical and medical device companies, with $92.89 received in 2023. These payments were reported across 59 transactions from 11 companies. The most common payment nature is "Food and Beverage" ($895.54).
As a Medicare-enrolled provider, Pons has provided services to 110 Medicare beneficiaries, totaling 210 services with total Medicare billing of $19,839. Data is available for 3 years (2020–2022), covering 5 distinct procedure/service records.
Ad
Practice Information
- Specialty Infectious Disease
- Location Novato, CA
- Active Since 08/09/2010
- Last Updated 03/07/2023
- Taxonomy Code 207RI0200X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1609181213
Products in Payments
- DALVANCE (Drug) $345.16
- Symtuza (Drug) $144.59
- VIBATIV (Drug) $111.67
- Baxdela (Drug) $55.64
- AVYCAZ (Drug) $52.67
- TEFLARO (Drug) $42.32
- FLEXITOUCH (Device) $28.46
- CABENUVA (Biological) $24.95
- Xerava (Drug) $23.40
- PREZCOBIX (Drug) $13.12
- Mavyret (Drug) $12.66
- ZERBAXA (Drug) $12.53
- Santyl (Drug) $11.19
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.